Immunogenicity and reactogenicity of a single dose of a diphtheria–tetanus–acellular pertussis component vaccine (DTaP) compared to a diphtheria–tetanus toxoid (Td) and a diphtheria toxoid vaccine (d) in adults
- 30 April 2001
- journal article
- clinical trial
- Published by Elsevier BV in Vaccine
- Vol. 19 (23-24), 3137-3145
- https://doi.org/10.1016/s0264-410x(01)00029-9
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- A randomised controlled trial with a diphtheria–tetanus–acellular pertussis (dTpa) vaccine in adultsVaccine, 2000
- An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adultsVaccine, 1999
- A Randomized Clinical Trial of Acellular Pertussis Vaccines in Healthy Adults: Dose?Response Comparisons of 5 Vaccines and Implications for Booster ImmunizationThe Journal of Infectious Diseases, 1999
- Diphtherie-Auffrischimpfung bei ErwachsenenDeutsche Medizinische Wochenschrift (1946), 1997
- Diphtheria antitoxin titres six years after basic immunization of adultsVaccine, 1996
- Pertussis in adults: frequency of transmission after household exposureThe Lancet, 1995
- Pertussis in German AdultsClinical Infectious Diseases, 1995
- The Changing Epidemiology of Pertussis in Young InfantsAmerican Journal of Diseases of Children, 1978
- Pertussis in the AdultAnnual Review of Medicine, 1977
- Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cellsJournal of Biological Standardization, 1974